The Pfizer/BioNTech vaccine is an updated booster and the second bivalent to receive approval from the medicines watchdog.
Free to registered users
Register to gain full access to C+D and C+D Community content
Already registered?
MHRA approves second Pfizer/BioNTech COVID-19 booster vaccine
The Medicines and Healthcare Products Regulatory Authority (MHRA) has approved a bivalent COVID-19 vaccine that targets the original strain of SARS-CoV-2 and two Omicron sub-variants.
Sign in or register for free
Already registered?
Latest from News
• By
• 
Chair of the National Pharmacy Association (NPA) Nick Kaye has said that he “definitely wouldn't be thinking about a U-turn” on collective action, amid “real anger” over a lack of April cash.
• By
• The pharmacy hypertension service specification is set to be updated to exclude patients who request “frequent measurement of their blood pressure”.
• By
• CPE is recruiting a new independent chair to “provide strategic leadership” – the position pays £50k a year and only requires a “time commitment” of 3-4 working days per calendar month.